CBOA
BSX icon

Commonwealth Bank of Australia’s Boston Scientific BSX Stock Holding History

Commonwealth Bank of Australia’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-42,596
Closed -$1.82M – 150
2019
Q2 		$1.82M Sell
42,596
-7,159
-14% -$275K 0.02% 425
2019
Q1 		$1.9M Sell
49,755
-6,700
-12% -$256K 0.02% 423
2018
Q4 		$1.99M Buy
56,455
+2,723
+5% +$98.8K 0.02% 374
2018
Q3 		$2.06M Sell
53,732
-2,200
-4% -$76.8K 0.02% 398
2018
Q2 		$1.7M Sell
55,932
-10,001
-15% -$302K 0.02% 403
2018
Q1 		$1.79M Sell
65,933
-9,882
-13% -$269K 0.02% 384
2017
Q4 		$1.87M Sell
75,815
-3,022
-4% -$83.3K 0.02% 403
2017
Q3 		$2.29M Buy
78,837
+5,265
+7% +$145K 0.02% 355
2017
Q2 		$2.04M Buy
73,572
+5,919
+9% +$157K 0.02% 372
2017
Q1 		$1.68M Buy
67,653
+4,753
+8% +$116K 0.02% 389
2016
Q4 		$1.36M Sell
62,900
-1,229
-2% -$26.8K 0.02% 417
2016
Q3 		$1.53M Sell
64,129
-9,300
-13% -$222K 0.02% 374
2016
Q2 		$1.72M Sell
73,429
-1,258
-2% -$27.2K 0.02% 351
2016
Q1 		$1.41M Sell
74,687
-10,506
-12% -$185K 0.02% 390
2015
Q4 		$1.57M Sell
85,193
-29,094
-25% -$521K 0.02% 366
2015
Q3 		$1.88M Sell
114,287
-440
-0.4% -$7.52K 0.02% 334
2015
Q2 		$2.03M Sell
114,727
-9,612
-8% -$172K 0.03% 286
2015
Q1 		$2.21M Buy
124,339
+4,900
+4% +$77.4K 0.03% 285
2014
Q4 		$1.58M Sell
119,439
-26,628
-18% -$340K 0.02% 335
2014
Q3 		$1.73M Buy
146,067
+6,900
+5% +$86.9K 0.02% 355
2014
Q2 		$1.78M Sell
139,167
-183,326
-57% -$2.38M 0.02% 343
2014
Q1 		$4.36M Sell
322,493
-29,985
-9% -$394K 0.03% 476
2013
Q4 		$4.24M Buy
352,478
+30,951
+10% +$366K 0.03% 458
2013
Q3 		$3.77M Sell
321,527
-42,200
-12% -$456K 0.03% 458
2013
Q2 		$3.37M Buy
+363,727
New +$3.09M 0.03% 467

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Commonwealth Bank of Australia's BSX Position: Q3 2019 in Review

Commonwealth Bank of Australia sold out of Boston Scientific (BSX) in Q3 2019, closing a stake of 42,596 shares — an estimated $1.82M sold.

Commonwealth Bank of Australia first reported a position in BSX in Q2 2013 and held it in 25 quarters. The position peaked at $4.36M in Q1 2014. 771 funds tracked by Wall St. Rank hold BSX as of Q3 2019.

  • Commonwealth Bank of Australia reported no remaining Boston Scientific position as of Q3 2019 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 42,596 Boston Scientific shares in Q3 2019, an estimated $1.82M.
  • Commonwealth Bank of Australia first reported a position in Boston Scientific in Q2 2013 and held it in 25 quarters.
  • Commonwealth Bank of Australia's Boston Scientific position peaked at $4.36M in Q1 2014.
  • 771 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2019.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2019.